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Abstract 20 
In-sewer transformation of drug biomarkers (excreted parent drugs and metab-21 
olites) can be influenced by the presence of biomass in suspended form as well 22 
as attached to sewer walls (biofilms). Biofilms are likely the most abundant 23 
and biologically active biomass fraction in sewers. In this study, 16 drug bi-24 
omarkers were selected, including the major human metabolites of 25 
mephedrone, methadone, cocaine, heroin, codeine and tetrahydrocannabinol 26 
(THC). Transformation and sorption of these substances were assessed in tar-27 
geted batch experiments using laboratory-scale biofilm reactors operated under 28 
aerobic and anaerobic conditions. A one-dimensional model was developed to 29 
simulate diffusive transport, abiotic and biotic transformation and partitioning 30 
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of drug biomarkers. Model calibration to experimental results allowed estimat-31 
ing transformation rate constants in sewer biofilms, which were compared to 32 
those obtained using in-sewer suspended biomass. 33 
Our results suggest that sewer biofilms can enhance the transformation of most 34 
compounds. Through scenario simulations, we demonstrated that the estima-35 
tion of transformation rate constants in biofilm can be significantly biased if 36 
the boundary layer thickness is not accurately estimated. This study comple-37 
ments our previous investigation on the transformation and sorption of drug 38 
biomarkers in the presence of only suspended biomass in untreated sewage. A 39 
better understanding of the role of sewer biofilms–also relative to the in-sewer 40 
suspended solids–and improved prediction of associated fate processes can 41 
lead to more accurate estimation of daily drug consumption in urban areas in 42 
wastewater-based epidemiological assessments. 43 
Introduction 44 
Wastewater-based epidemiology (WBE) has emerged as a new paradigm to 45 
monitor trends of community-wide drug use based on chemical analysis of uri-46 
nary drug biomarkers in raw sewage, typically in the influent of wastewater 47 
treatment plants (WWTPs).1,2 Transport in upstream sewer pipelines is known 48 
to influence the quality of untreated wastewater3, hence reliable estimations of 49 
drug use based on observations in WWTP influents  require consideration of 50 
in-sewer transformations and sorption of biomarkers. A recent investigation4 51 
in a full-scale pressurized sewer pipeline revealed significant elimination or 52 
formation of pharmaceuticals (e.g. bezafibrate and sulfamethoxazole, respec-53 
tively). 54 
The uncertainty introduced by neglecting in-sewer processes is often ignored5 55 
among other sources of uncertainty in WBE studies.6 The in-sample stability 56 
of drug biomarkers has been widely assessed7–10, providing an indication of 57 
biotransformation in raw wastewater. These studies prominently addressed the 58 
reliability of analysis after sample collection, focusing e.g. on biomarker sta-59 
bility during composite sample collections, rather than refining back-calcula-60 
tion schemes by accounting for in-sewer transformations. However, due to dif-61 
ferences in operation and design of sewer systems, in-sewer stability of drugs 62 
of abuse is not only compound-specific but also highly dependent upon the 63 
catchment layout (e.g., size11) and the hydraulic conditions in the pipelines.  64 
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Moreover, in-sewer fate processes are not limited to biotransformation in the 65 
bulk phase and biofilms/sediments, but also include abiotic processes and par-66 
titioning of drug biomarkers to suspended and attached solids. Drug bi-67 
omarkers can be in-sewer transformation product of other human metabolites 68 
and hence their concentration can be significantly influenced. When consider-69 
ing these challenges, chemical stability in terms of percentage removal effi-70 
ciency or correction factors (lumped factors that include excretion ratio, in-71 
sewer transformation etc.) cannot be a reliable source of information for the 72 
estimation of drug load at the point of excretion.  73 
Recently, transformation and sorption of several drug biomarkers in raw 74 
wastewater in the presence of suspended biomass have been assessed using 75 
targeted experiments and mechanistic modelling.12 This previous study eluci-76 
dated the role of only one of the possible actors of in-sewer biochemical pro-77 
cesses, as biomass in sewer systems is present also in attached form. However, 78 
limited evidence exists on the role of sewer biofilms. To date, only a few stud-79 
ies13,14 assessed removal kinetics in sewer biofilms, showing enhanced relative 80 
removal efficiency of selected drug biomarkers (cocaine and 6-mono-acetyl-81 
morphine) as compared to raw wastewater. Nevertheless, a number of previ-82 
ously uninvestigated factors are likely to influence (the estimation of) biofilm-83 
mediated transformation rates, namely (i) sorption onto biofilm15, similarly to 84 
suspended solids in untreated wastewater12; (ii) concurrent transformation and 85 
formation from other biomarkers8,12,16,17; (iii) abiotic degradation5,12; (iv) pre-86 
vailing redox conditions (aerobic and anaerobic); and (v) diffusive transport 87 
through boundary layer and in biofilm15,18. While being typically neglected in 88 
biotransformation studies with biofilms, The impact of (v) may be substantial 89 
considering the structure and the thickness of sewer biofilms and the reduced 90 
diffusivity of large organic molecules.19–21 This is especially important in pres-91 
surized sewers, where sewer biofilms are abundant in completely filled 92 
pipes.3,22 93 
In this study, we sought to improve the existing understanding of the fate of 94 
drug biomarkers in the presence of sewer biofilms by means of an experimental 95 
and model-based assessment. This study was meant to complement our previ-96 
ous investigation12 on the fate of drug biomarkers in untreated sewage, in the 97 
presence of only suspended biomass. The objectives of our investigation were 98 
thus: (i) to assess the transformation and sorption of 16 drug biomarkers in 99 
sewer biofilms under aerobic and anaerobic conditions (using laboratory-scale 100 
rotating biofilm reactors); (ii) to model the fate of selected drug biomarkers in 101 
the biofilm by explicitly describing diffusive transport and reaction kinetics; 102 
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(iii) to estimate biofilm-mediated biotransformation kinetics for the selected 103 
biomarkers, and to compare them with transformation kinetics by suspended 104 
biomass in untreated wastewater. 105 
Materials and methods 106 
Selection of trace organic biomarkers. Six illicit drugs were selected based 107 
on their high consumption levels according to a recent European report.23 The 108 
target list was completed with 10 human metabolites and included: (i) 109 
mephedrone (MEPH); (ii) methadone (METD) and its metabolite 2-ethylidene-110 
1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP); (iii) cocaine (COC) and its me-111 
tabolites benzoylecgonine (BE), ecgonine methyl ester (EME), and co-112 
caethylene (CE); (iv) heroin (HER) and its metabolites 6-monoacetylmorphine 113 
(6-MAM), morphine (MOR), and morphine-3-β-D-glucuronide (MORG); co-114 
deine (COE) and its metabolite norcodeine (NCOE); (v) tetrahydrocannabinol 115 
(THC) and its metabolites 11-hydroxy-Δ9-THC (THCOH), and 11-nor-9-car-116 
boxy-Δ9-THC (THCCOOH). COE and NCOE were also considered in the 117 
same group as MOR, since COE can potentially transform to MOR and NCOE 118 
during human metabolism.24 Analytical Standards (IS) and isotopically labeled 119 
internal standard (ILIS) analogues from Sigma Aldrich (Brøndby, Denmark) 120 
were dissolved in methanol or acetonitrile at concentrations of 0.1 mg mL-1 121 
and 1 mg mL-1, respectively. Poor data quality prevented us from assessing the 122 
transformation of methamphetamine and amphetamine, which are widely used 123 
in Europe.23 124 
Experimental set-up with continuous-flow operation. Two annular rotating 125 
biofilm reactors, made of poly(methyl methacrylate) (Plexiglas), operated ei-126 
ther under aerobic or anaerobic conditions with operating volume of 0.961 L, 127 
were used to simulate in-sewer conditions by controlling, e.g., shear conditions 128 
on biofilm. The reactors consisted of an inner rotating drum (diameter=9.0 cm) 129 
and an outer stationary cylinder (diameter=11.4 cm), supporting the growth of 130 
attached biomass. This type of reactor provided for high surface area to volume 131 
ratio (175 m2 m-3) that could be advantageous for biofilm growth. Each reactor 132 
was equipped with four removable slides, allowing for inspection of biofilm 133 
during reactor operation.  134 
In order to establish stable aerobic and anaerobic biofilms, the two reactors were 135 
operated under continuous-flow conditions for more than 7 months while being 136 
kept in the dark. The rotation speed of the reactors was set to 20 rpm. The wall 137 
shear stress was calculated according to equations provided by Rochex et al.25 as 138 
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0.05 Pa which is in the lower range of typical wall shear stress in the sewers, meas-139 
ured up to 3 Pa in a gravity sewer.26 Low shear stress was chosen in order to de-140 
crease biofilm sloughing and therefore enhance biofilm thickness. The reactors 141 
were continuously fed (4 L d-1, hydraulic residence time of approximately 0.25 142 
d-1) with pre-clarified wastewater from external cooled containers (T ≤ 4°C) 143 
that were sparged with dry compressed atmospheric air (aerobic reactor) or 144 
nitrogen (anaerobic reactor). The experiments were performed to mimic com-145 
pletely aerobic and anaerobic redox conditions. The external tanks were filled with 146 
pre-clarified wastewater collected from Mølleåværket WWTP (Lundtofte, Den-147 
mark) semi-weekly. The wastewater had following characteristics: soluble organic 148 
carbon, expressed as chemical oxygen demand (COD) = 40–130 g m-3, total COD 149 
(120–g m-3), biological oxygen demand (BOD) = 90–200 g m-3, nitrate < 1 gN m-150 
3, total nitrogen (TN) = 20–50 gN m-3, sulfate = 12-55 gS m-3. 151 
 152 
Laboratory-scale batch experiments. Following long-term continuous-flow 153 
operation, two sets of batch experiments were performed: (i) biotransformation 154 
experiments with intact biofilm in rotating reactors (BT); and (ii) sorption ex-155 
periments with re-suspended biofilm (SO). All experiments were started (t=0) 156 
three minutes after spiking of biomarker standard solutions to ensure mixing 157 
of spiked biomarkers in solution. Figure 1 illustrates the reactor configuration 158 
and operation during BT Experiments. During the entire operation, the biofilm 159 
reactors were kept full and intermittent wetting was avoided to prevent reduc-160 
tion of the overall activity of the biofilm. A detailed description of each set of 161 
batch experiments is provided below. Description of all batch experiments is 162 
also presented in SI Table S2. 163 
Biotransformation experiments (BT). Each rotating biofilm reactor was con-164 
nected to an external container with a recirculating flow of 4 L h-1. This con-165 
figuration allowed for sample collection from the external container without 166 
changing the operating volume of the biofilm reactors. Two procedures were 167 
considered. The first procedure (BT-P1) was conducted by spiking a mixture 168 
containing all IS to obtain an initial (t=0) concentration of 10 μg L-1. Following 169 
sample withdrawal during experiments, samples were immediately spiked with 170 
a mixture containing ILIS. The IS solution mixture contained the main target 171 
compounds and ILIS were used to evaluate the analytical procedure. The sec-172 
ond procedure (BT-P2) was conducted by spiking ILIS at initial (t=0) concen-173 
tration of 2 μg L-1. In this second case only ILIS were spiked and considered 174 
the target compounds, including only MEPH-d3, METD-d3, EDDP-d3, COC-175 
d3, BE-d3, EME-d3, CE-d3, HER-d9 and 6MAM-d3. This procedure allowed 176 
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for the improved determination of illicit drug analytes without interference of 177 
background concentrations (SI, Figure S3).13  178 
The duration of the experiments was two days, during which 9 samples for BT-179 
P1 and 12 samples for BT-P2 experiments were collected (around 260 mL sam-180 
ple volume, see SI, Figure S2). During BT-P1 experiments, additional samples 181 
were collected (i) before biomarker spiking, to measure the background con-182 
centrations; and (ii) during experiments, to monitor the biological activity of 183 
the biofilms via measurements of chemical oxygen demand (COD), sulfate 184 
(SO4-S), ammonium (NH4-N) and nitrate (NO3-N).  185 
BT-P1 and BT-P2 experiments were conducted after continuous-flow opera-186 
tion of biofilm reactors for 14 and 7 months, respectively assuming biofilm 187 
reached maximum thickness.  In this study, results of BT-P1 and BT-P2 exper-188 
iments were used for model identification/calibration (i.e., estimation of ki-189 
netic parameters and identification of transformation pathways) and for model 190 
evaluation, respectively. For BT-P1 experiments (aerobic: pH=8.7±0.1, 191 
T=17±0.3 °C; anaerobic: pH=9.2±0.4, T=17.8±0.5 °C), and BT-P2 experi-192 
ments (aerobic: pH=8.8±0.06, T=17.6±0.2 °C; anaerobic: pH=8.7±0.2, 193 
T=17.5±0.4°C), wastewater was collected from Mølleåværket WWTP 194 
(Lundtofte, Denmark). Collected pre-clarified wastewater was centrifuged (20 195 
min, 4700 rpm) and vacuum filtered (Advantec MFS, Inc., GA-55 grade) for 196 
removal of suspended solids.  197 
Sorption experiments (SO). Sorption experiments (SO) were performed with 198 
suspended aerobic biofilms (SO1) and suspended anaerobic biofilms (SO2). 199 
The experiments were conducted after 14 months of continuous-flow operation 200 
of the biofilm reactors. Tap water was circulated through the biofilm reactors 201 
for 17 h to wash-off already sorbed compounds in the biofilm. Two slides were 202 
removed from each reactor and intact biofilm was suspended in 2 L tap water 203 
for 4 h for further desorption. After centrifugation (30 min, 4700 rpm), the 204 
separated solids were mixed with 4 L vacuum filtered (Advantec MFS, Inc., 205 
GA-55 grade, pore size 6 μm) wastewater effluent (Mølleåværket WWTP, 206 
Lundtofte, Denmark). To inactivate biomass during experiment, sodium azide 207 
(0.05% v/v) was added to the mixture. The experiments were conducted for 4 208 
h after spiking standard mixture and in total six samples (260 mL) were with-209 
drawn. During SO1 experiment (pH=7.9±0.1, T=15.4±0.2°C) and SO2 exper-210 
iment (pH=7.9±0.1, T=15.3±0.1 °C), the reactors were sparged with dried com-211 
pressed air and nitrogen, respectively. 212 
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Biofilm characterization. The biofilm thickness (aerobic: 0.75 mm; anaero-213 
bic: 1.02 mm) was calculated by measuring biofilm volume and considering 214 
the reactor surface area of 1679 cm2. The biofilm volume was measured by 215 
filling the rotating reactors with tap water without and with biofilm inside the 216 
reactors. The difference between the volume of the empty reactor without bio-217 
film (961 cm3) and the free volume of the reactors with biofilm (aerobic reac-218 
tor, 836 cm3; anaerobic reactor, 790 cm3) was considered as the wet biofilm 219 
volume. The solids content of the biofilm was measured by re-suspending the 220 
biofilm on two removable slides into tap water, and subsequently measuring 221 
total suspended solids (TSS) and volatile suspended solid (VSS) of the mixture. 222 
The total dried mass per biofilm volume in the reactors, defined as biofilm 223 
density, was then calculated (aerobic reactor, 55 gTSS L-1, 22 gVSS-1 L-1; an-224 
aerobic reactor, 83 gTSS L-1, 38 gVSS-1 L-1).  225 
Sample preparation and chemical analyses. Total suspended solids (TSS) 226 
were measured using gravimetric analysis after filtration (0.6 μm glass fiber 227 
filter, Advantec, USA).27 Total and soluble COD, nitrate, ammonium and sul-228 
fate were measured using colorimetric methods (Hach Lange and Merck, Ger-229 
many). For dissolved components, the analyses were carried out after sample 230 
filtration (0.45 μm cellulose acetate filters, Sartorius, Germany) and storage at 231 
-20 °C. 232 
For the analysis of drug biomarkers (one sample at each sampling time), a de-233 
scription of sample preparation and chemical analysis by liquid chromatog-234 
raphy coupled to high resolution mass spectrometry (HPLC-LTQ-Orbitrap) 235 
can be found elsewhere.12,28 Briefly, samples were collected and immediately 236 
frozen until analysis. For samples from SO experiments samples were first fil-237 
tered (0.6 μm glass fiber filter, Advantec, USA) to reduce the contact time 238 
between solids and liquid phase. Later, samples were thawed and homoge-239 
nized, and 100 mL aliquots were extracted by solid phase extraction with Oasis 240 
HLB cartridges (150 mg, 6 cc, Waters, Denmark). Extracts were reconstituted 241 
in water:methanol (90:10, v/v)  and 20 µL were injected into the HPLC-LTQ-242 
Orbitrap. Separation of the target compounds was achieved in an XBridge C18 243 
column (150 mm × 2.1 mm, I.D., particle size 3.5 μm; Waters) with a MiliQ 244 
and MeOH optimized gradient (each with 0.05% formic acid). Full scan accu-245 
rate mass data were acquired in positive electrospray ionization mode over a 246 
m/z range of 50–600 Da at a resolution of 30000 full width at half maximum. 247 
For confirmation purposes, information about the fragmentation spectra of the 248 
target compounds was obtained by product-ion scan mode of the target masses 249 
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inclusion list, in the same analysis. All data were acquired and processed using 250 
Xcalibur version 2.1 software. 251 
Modeling framework. The mathematical description of fate processes was 252 
formulated by accounting for temporal and spatial variation of target analyte 253 
concentrations in biofilms. Due to mass transfer limitation from the bulk phase 254 
to the biofilm and within the biofilm, concentration gradients can occur in the 255 
biofilm reactors. For the specific case of batch experiments, it was assumed 256 
that the biofilm is at steady state and as a homogeneous biomass. The volume 257 
inside the biofilm reactors was constant, whereas in the external tank the vol-258 
ume decreased due to withdrawal of samples. Thus, the contact time between 259 
the dissolved compounds in liquid phase and biofilm increased, which could 260 
potentially enhance biomarker transformation. Consequently, residence time 261 
dynamics were also included in the model by accounting for volume changes 262 
in the external tank (SI Figure S2). As illustrated in Figure 1, the experimental 263 
system consists of three compartments: (i) the bulk liquid in the rotating reac-264 
tor, (ii) the biofilm in the rotating reactor and (iii) the external tank (continu-265 
ously stirred tank reactor) connected to the biofilm reactor via a peristaltic 266 
pump. The differential equations describing mass balances in each compart-267 
ment can be formulated as follows (all model parameters and state variables 268 
are listed in Table 1):  269 
i) In the biofilm reactor bulk phase: 270 
ௗ ௏ೃ஼ೃ,೔
ௗ௧
= 𝑄௜௡,ோ𝐶௜௡,ோ,௜ − 𝑄௢௨௧,ோ𝐶ோ,௜ − 𝑗௕𝐴௕ + 𝑟ோ,௜𝑉ோ       (eq.1) 271 
ii) In the biofilm:  272 
ப ௏್஼್,೔
ப௧
= 𝐴௕𝐷
பమ஼್,೔
ப௭మ
∆𝑧 + 𝑟௕,௜𝑉௕                                   (eq. 2) 273 
iii) In the external tank: 274 
ௗ ௏೅஼೅,೔
ௗ௧
= 𝑄௜௡,்𝐶௜௡,்,௜ − 𝑄௢௨௧,்𝐶்,௜ + 𝑟 ,௜𝑉                      (eq. 3) 275 
In these formulations, C (g m-3) denotes the concentration as state variable and 276 
the subscripts R, b and T indicate bulk phase of the rotating reactor, the biofilm, 277 
and the external tank, respectively. The volume, which is constant for the re-278 
actor bulk phase VR (m-3) and the biofilm Vb (m-3), changes as a function of 279 
time inside the external tank, VT (m-3), as previously explained.  280 
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Transport processes. The flux of compounds between bulk phase and the bio-281 
film, jb (g m-2 d-1), is expressed using film theory at the mass transfer boundary 282 
layer29.  The flux of compounds across the boundary layer can be defined as: 283 
𝑗௕ = 𝑘௕(𝐶ோ − 𝐶௅) =
஽
௅್
(𝐶ோ − 𝐶௅)                                (eq. 4) 284 
Where kb (m d-1) is the liquid-biofilm mass transfer coefficient, D (m2 d-1) is 285 
the diffusion coefficient of the dissolved compounds into the biofilm, Lb (m) is 286 
the biofilm thickness, and CL is the concentration at the biofilm-liquid interface 287 
(top layer). It was assumed that no reactions occur in the boundary layer. The 288 
diffusion coefficients of target biomarkers in water, Dw (m2 d-1) were calculated 289 
based on the revised Othmer-Thakar30 equation suggested by Hayduk and 290 
Laudie31: 291 
𝐷௪ =
ଵଷ.ଶ଺ (ଵ଴షఱ)
ఓೢభ.ర௏భబ.ఱఴవ
  ,                                                  (eq. 5) 292 
where μw (kg m-1 s-1) denotes the dynamic viscosity of water and V1 (cm3 g 293 
mole-1) is the molar volume of the substance. Diffusion coefficients (DW) cal-294 
culated using eq. 5 are reported in Table S1. Diffusion coefficients inside the 295 
biofilm were assumed to be reduced as compared to bulk water phase. Reduced 296 
effective diffusivity results from limitation due to increased path length in bio-297 
film pores as compared to free aqueous media. Consequently, a dimensionless 298 
effective diffusivity factor, f, was considered: 299 
𝐷 = 𝑓𝐷௪                                (eq. 6) 300 
The value of f  was approximated by considering the density of the biofilm as 301 
VSS (gVSS L-1), based on the regression presented by Guimerà et al.32 The 302 
boundary layer thickness, Lb, was estimated using dimensionless numbers, 33,34 303 
namely Sherwood number (Sh), Schmidt number (Sc), Taylor number (Ta) and 304 
Reynolds number (Re), (see SI, eqs. S1 to S4).  305 
Reaction processes. Reaction kinetics in the bulk phase of the biofilm reactor 306 
includes abiotic processes and biotransformation due to the presence of sus-307 
pended biomass. The amount of suspended solids was the residuals of solids 308 
that remained in filtered wastewater (measured at t=0) and amount of detached 309 
biomass assumed to be negligible. These processes were formulated according 310 
to the Activated Sludge Model for Xenobiotics (ASM-X) framework.12,16 The 311 
reaction rate for transformation of compound i and its formation from com-312 
pound j can be formulated as: 313 
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𝑟ோ,௜ = −𝑘௔௕௜௢𝐶ோ,௜ + 𝑘௔௕௜௢𝐶ோ,௝
ெ೔
ெೕ
− ௞್೔೚௑ೄೄ
(ଵା௄೏,೔௑ೄೄ)
𝐶ோ,௜ +
௞್೔೚௑ೄೄ
(ଵା௄೏,ೕ௑ೄೄ)
𝐶ோ,௝
ெ೔
ெೕ
                         314 
(eq. 7) 315 
Where kabio (d-1) is the abiotic transformation rate, kbio (L gTSS-1 d-1) is the 316 
TSS-normalized biotransformation rate constant for the suspended solids, Kd 317 
(L gTSS-1) is the partitioning coefficient to suspended solids XSS (g L-1), and M 318 
is the molecular weight. Equilibrium processes were assumed for sorption and 319 
desorption onto suspended solids.  320 
Inside the biofilm, in addition to abiotic processes, transformation and for-321 
mation processes resulted from the microbial activity of the attached biomass. 322 
The associated kinetic equations were expressed as:  323 
𝑟௕,௜ = −𝑘௔௕௜௢𝐶ோ,௜ + 𝑘௔௕௜௢𝐶ோ,௝
ெ೔
ெೕ
− 𝑘௙,௜𝐶௕,௜ + 𝑘௙,௝𝐶௕,௝
ெ೔
ெೕ
                     (eq. 8) 324 
𝑘௙,௝ =
௞್೔೚೑,ೕ௑ೄೄ
(ଵା௄೏೑,ೕ௑ೄೄ)
                                                    (eq. 9) 325 
In this formulation, biofilm-mediated transformation (subscript f) is expressed 326 
using pseudo-first order kinetics, where kf and kbiof are in units of d-1 and L 327 
gTSS-1 d-1, respectively, and Kdf (L gTSS-1 d-1) is the partitioning coefficient in 328 
biofilms. Biofilm-mediated transformation can also be expressed by surface-329 
normalized rate constants k’biof  (m3 m-2 d-1), obtained by dividing kbiof with 330 
XSS·×Ab/Vb. The units of the reactions rates were adjusted to g m3 d-1 according 331 
to the units in eq. 1-3. 332 
Finally, the reaction kinetics in the external tanks were assumed to be the same 333 
as in the bulk aqueous phase of the biofilm reactor, with additional processes 334 
for sorption and desorption to and from the tank wall12:  335 
𝑟 ,௜ = 𝑟ோ,௜ − 𝑘ௗ௘௦,௪𝑘ௗ,௪𝐶்,௜
஺೅
௏೅
+ 𝑘ௗ௘௦,௪𝐶்௪                 (eq. 10) 336 
Where CTw (g L-1) denotes the biomarker concentration sorbed onto reactor 337 
wall, Kd,w (m3 m-2 d-1) the partitioning coefficient to reactor wall. and kdes,w (d-338 
1) is the desorption rate from the reactor wall.  339 
In-sewer transformation pathways. Transformation and formation processes 340 
defined in eqs. 7–10 depend on the pathways identified for abiotic processes, 341 
transformation due to presence of suspended solids and biofilm-mediated 342 
transformations. The first two were adopted from our previous study.12 Trans-343 
formation pathways in biofilms were initially assumed based on reported hu-344 
man metabolic pathways.7,35 This initial assumption was required due to the 345 
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absence of a priori evidence and was tested as part of the modelling study. 346 
Subsequently, any deviation from the initial pathways was assessed by exam-347 
ining the mass balance over suggested transformed compounds and observed 348 
transformation products (according to human metabolism).   349 
Model parameter estimation. The values employed for kabio and kbio for sus-350 
pended biomass in bulk phase were estimated in an another study.12 Using SO1 351 
and SO2 measurements (SI, Figure S8) the Kdf  values were estimated accord-352 
ing to Ramin et al.12 Values of kf were estimated using the Bayesian optimiza-353 
tion method Differential Evolution Adaptive Metropolis (DREAM(ZS)).36 The 354 
normalized sum of squared error (SSE) was used as objective function: 355 
2
1 1 min,,max,,
,,
 











n
i
m
j jiji
jiji
OO
PO
SSE       (eq. 11) 356 
Where n is the number of measurements series and m is the number of the data 357 
points in each series. O denotes measured data, P model predictions, and Oi,j,max 358 
and Oi,j,min  the maximum and minimum of measurements, respectively. To ad-359 
equately quantify the uncertainty associated to the kf estimates, the uncertainty 360 
from kabio and kbio was propagated according to the identified transformation 361 
pathways for abiotic processes and biotransformation in presence of suspended 362 
solids.37 Values of kbiof were eventually estimated based on eq. 9. We consid-363 
ered an upper boundary threshold of 104 d-1 for kf in parameter estimation. Pa-364 
rameter estimates beyond this threshold were considered to result from model 365 
structure deficiencies (related to mass transfer).  366 
Model simulation and evaluation. To simulate the transformation processes, 367 
eqs. 1–3 were numerically solved following a spatial discretization of the bio-368 
film. Theoretically, increasing the discretization level (grid points) would in-369 
crease the accuracy of prediction at the expense of higher computational time. 370 
For central grids (inside the biofilm), discretization was done using the central 371 
difference formula. Values at the first grid (biofilm-liquid interface) and the 372 
last grid points were computed via forward and backward difference, respec-373 
tively. This discretization scheme was adopted from the biofilm simulation 374 
model developed by Vangsgaard et al.38 The resulting set of ordinary differen-375 
tial equations was solved using the stiff ODE solver ode15s in Matlab R2014a 376 
(MathWorks, US). Model parameter uncertainty was assessed using the poste-377 
rior probability distribution of estimates in Monte Carlo simulations as ex-378 
plained elsewhere.39 Subsequently, the accuracy of the predictions was visually 379 
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evaluated comparing measurements from BT-P2 experiments, i.e. an independ-380 
ent dataset, with model predictions.  381 
Results and discussion 382 
Biological activity of biofilm reactors. To monitor microbial activity in aer-383 
obic and anaerobic biofilms, soluble COD, sulfate and ammonium (Figure 2) 384 
as well as total COD and nitrate (SI, Figure S4) were monitored in the bulk 385 
phase during the BT-P1 experiments (while reactors were disconnected from 386 
continuous feeding). Soluble COD consisted of readily biodegradable organic 387 
substrates and soluble inert fractions, including MeOH present in the spiking 388 
solution. Utilization of MeOH as growth substrate was assumed to be negligi-389 
ble as in our previous study12 we did not observe any substantial difference in 390 
suspended biomass growth and oxygen uptake response upon MeOH addition. 391 
Due to the likely higher activity of heterotrophic biomass under aerobic con-392 
ditions as well as higher MeOH evaporation rate (dried air was sparged at a 393 
higher flow rate in the external tank compared to nitrogen gas), higher removal 394 
of soluble COD was observed in the aerobic reactor (88%) compared to the 395 
anaerobic one (57%) over 2 d. Due to the activity of sulfate reducing bacteria 396 
(SRB), sulfate was significantly reduced under anaerobic conditions (62% over 397 
1 d) and remained constant during last day of experiment (Figure 2b). This may 398 
indicate that sulfate respiration by SRB species was limited by the absence of 399 
readily biodegradable substrate during the second day of experiment. Under 400 
aerobic conditions, the net formation (+33%) of sulfate was observed over 2 d, 401 
possibly due to biochemical oxidation of hydrogen sulfide (H2S) back to sul-402 
fate. In the aerobic BT-P1 reactor, ammonium removal is possibly dominated 403 
by assimilatory ammonia uptake. It is also reported that nitrifiers are usually 404 
overgrown by heterotrophic biomass in sewer biofilms (Huisman and Gujer, 405 
2002; Jiang et al., 2009). Under anaerobic conditions, ammonium removal 406 
could be due to assimilation and stripping – latter due to the comparably high 407 
pH (9.2). 408 
  409 
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Partitioning of drug biomarkers to biofilm. Two solid-liquid partitioning 410 
coefficients were estimated for aerobic (Kdf,ae) and anaerobic biofilms (Kdf,an) 411 
using SO1 and SO2 experimental data, respectively (SI Figure S8). In addition, 412 
abiotic chemical transformation was assessed in mineral water spiked with the 413 
selected biomarkers – a study carried out previously.12 These data were con-414 
sidered to disregard the contribution of abiotic transformation during sorption 415 
experiments. Estimated partitioning coefficients are reported in SI Table S4. 416 
The highest sorption capacity was found for THCOH (Kdf,ae=2.81 L gTSS-1; 417 
Kdf,an=1.68 L gTSS-1). The drop in THC concentration in the sorption experi-418 
ments (72% in aerobic biofilms and 58% in anaerobic biofilm) can be inter-419 
preted as a result of chemical partitioning to external tank wall, as it was ob-420 
served previously12, with the Kdf values being negligible despite the high hy-421 
drophobicity of this chemical (logKow=7.6).40 However, given the high hydro-422 
phobicity of THC, high sorption onto biofilm solids could not be ruled out, and 423 
further experimental confirmation may be required to verify our findings. Sorp-424 
tion of THCCOOH, EME and EDDP was only observed for anaerobic biofilms 425 
(Kdf,an=1.06 L gTSS-1; 1.59 L gTSS-1; Kdf,an=0.15 L gTSS-1 respectively). Con-426 
versely, partitioning under aerobic conditions was found for MEPH 427 
(Kdf,ae=0.20 L gTSS-1). For the remaining chemicals, negligible sorption was 428 
observed, hence Kdf values were set to zero. Notably, the anaerobic biofilm had 429 
higher thickness and density compared to the aerobic biofilm, which may ex-430 
plain the selective sorption of some of the drug biomarkers.  431 
Transformation of drug biomarkers. Measurements from BT-P1 experi-432 
ments were used to calibrate developed 1-D model and to predict temporal and 433 
spatial concentration profiles of drug biomarkers in the presence of sewer bio-434 
films. Biotransformation due to the presence of suspended solids was ac-435 
counted for by including previously estimated kbio (L gTSS-1 d-1)12,37 (SI, Table 436 
S3). Measured TSS concentrations in the bulk were considered constant, 437 
namely, 42 mgTSS L-1 and 104 mgTSS L-1 (for BT-P1 aerobic and anaerobic, 438 
respectively) 92 mgTSS L-1 and 80 mgTSS L-1 (for BT-P2 aerobic and anaero-439 
bic, respectively). The abiotic transformation rates kabio and partitioning coef-440 
ficients of drug biomarkers to suspended solids, Kd (L gTSS-1), were set at 441 
values reported in SI, Table S3.12 Subsequently, biofilm-mediated biotransfor-442 
mation rates kf (d-1) and rate constants kbiof (L gTSS-1 d-1) and k’biof (m3 m-2 d-443 
1) were estimated.  444 
Measured and simulated concentration profiles of all targeted biomarkers, ob-445 
tained through model calibration and validation, are presented in Figure 3. Ex-446 
perimental and simulation results describe removal and formation of selected 447 
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drug biomarkers in the bulk phase of the biofilm reactor, where samples were 448 
collected. The simulation results obtained through model calibration are pre-449 
sented using the median of the estimated parameters (full and dash lines) with 450 
the corresponding 95% credibility interval (shaded uncertainty band). The un-451 
certainty boundary ranges, shown in Figure 3, were obtained through the prop-452 
agation of the uncertainties from abiotic and biotic transformation rates (quan-453 
tified here or previously12) to the model outputs. The transformation pathways 454 
identified in this study are presented in Figure S6–7. Parameter values esti-455 
mated (reported as median ± credibility interval) are listed in Table S5 and all 456 
posterior distributions of kf values are given in Figure S11. Experimental and 457 
modelling results are presented and discussed in detail for each group of chem-458 
icals in the following paragraphs.  459 
Prior to estimating values of kf, the impact of discretization number (i.e. the 460 
number of layers in which the biofilm is discretized) on the prediction accuracy 461 
was assessed. The case of the aerobic transformation rates for MEPH, kf,ae,MEPH, 462 
and HER, kf,ae,HER, is discussed in detail (Figure 4, X-Z axis; Figure S5). HER 463 
and MEPH were chosen because they represent compounds with low and high 464 
removal rate, respectively. Discretization numbers, selected in the interval of 465 
5-100 layers, were used to estimate kf and using the highest level used to bench-466 
mark the level of error introduced by inaccurate model simulations. The dif-467 
ference is reported as relative percentage error, in which best-fit estimates for 468 
kf,ae,HER and kf,ae,MEPH  were compared with their corresponding reference values, 469 
214.1 d-1 and 24.3 d-1, respectively. It was observed that the number of dis-470 
cretization had a different impact on the estimated kf of these two chemicals, 471 
and that after 80 grid points the resulting error was negligible (< 1 %) and 472 
independent of the discretization number. This discretization number corre-473 
sponds to 𝛥Z=9.3 μm and 𝛥Z=12.8 μm for aerobic and anaerobic biofilms, 474 
respectively.  475 
Mephedrone. MEPH removal was more pronounced in the aerobic reactor 476 
(77% versus 47% in the anaerobic reactor). Higher partitioning to aerobic bio-477 
films resulted in much higher biotransformation rate constants under aerobic 478 
conditions (kbiof,ae,MEPH=5.89 L gTSS-1 d-1, kbiof,an,MEPH=0.08 L gTSS-1 d-1). The 479 
comparably high sorption of MEPH in aerobic biofilms (Kdf,ae=0.2 L gTSS-1) 480 
makes this compound less bioavailable for microbial transformation. This im-481 
pact is also reflected in eq. 9, in which kbiof is in the numerator and Kdf is in 482 
denominator. Moreover, the higher aerobic kbiof obtained in this study agrees 483 
well with those reported previously12 (kbio,ae,MEPH=1.86 L gTSS-1 d-1, 484 
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kbio,an,MEPH=0 L gTSS-1 d-1). The model could adequately simulate BT-P2 da-485 
taset under both redox conditions, thereby validating the process model struc-486 
ture identified.  487 
Methadone. Since formation of EDDP after rapid removal of METD, especially 488 
under aerobic conditions, was not observed (Fig. 3), these chemicals were consid-489 
ered to have independent pathways – similar to that obtained with suspended in-490 
sewer solids.12 Our analyses showed rather small deviation between duplicates 491 
(sample analysis), i.e. ≤7.5% for METD and ≤4.5% for EDDP. 492 
Biotransformation of METD in sewer biofilms was found to be significantly 493 
faster under aerobic conditions (kbiof,ae,METD=2488 L gTSS-1 d-1, kbiof,an,METD=183 494 
L gTSS-1 d-1), which agrees well with data obtained with in-sewer suspended 495 
solids.12 Conversely, enhanced anaerobic transformation was observed for 496 
EDDP (kbiof,ae,EDDP=1.79 L gTSS-1 d-1, kbiof,an,EDDP=88.9 L gTSS-1 d-1). Simula-497 
tion results (Fig. 3) for EDDP (both redox conditions) as well as for METD 498 
(only anaerobic conditions) indicate a systematic deviation between the pre-499 
dicted and measured values. This may imply that the model structure should 500 
be re-evaluated in future studies. A possible explanation could be related to 501 
cometabolic effects, i.e. primary substrate oxidation can enhance secondary 502 
substrate (i.e. drug biomarker) biotransformation.41–43 Additionally, under an-503 
aerobic conditions, the sulfate remained constant after day 1 (Figure 2b). This 504 
may suggest that readily biodegradable substrates were depleted during the 505 
second day of experiment, resulting in negligible removal of EDDP and 506 
METD. Nevertheless, simulations could not well predict the BT-P2 dataset es-507 
pecially for METD, in which lower removal was observed as compared to BT-508 
P1 measurements, as the process model do not account for cometabolic effects. 509 
Cocaine. The transformation pathways for COC and its human metabolites 510 
were selected based on Bisceglia et al.44 Although the biotransformation of 511 
COC to EME has been reported to be almost insignificant in raw wastewater 512 
and activated sludge16,45, in this study EME was considered as a transformation 513 
product (Fig. S6d) of COC in sewer biofilms. Accordingly, it has been reported 514 
that, in sewer biofilms, there should be another major transformation product 515 
from COC other than BE as it was speculated previously.13 Net removal of 516 
COC, CE and EME and net formation of BE was observed over the duration of 517 
experiments, where BE formation resulted from hydrolysis of COC and CE.12,44 518 
Under aerobic conditions, the overall biotransformation rate constant of COC, 519 
i.e. COC to BE and COC to EME, was lower than under anaerobic conditions 520 
(kbiof,ae,COC=0.44 L gTSS-1 d-1, kbiof,an,COC=2.57 L gTSS-1 d-1). An even more 521 
pronounced deviation was observed for EME (kbiof,ae,EME=0.05 L gTSS-1 d-1, 522 
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kbiof,an,EME=21.03 L gTSS-1 d-1), mainly due to the high biotransformation of 523 
EME in the bulk phase under aerobic conditions, SI Table S3. Aerobic and 524 
anaerobic percentage removal of COC only by sewer biofilms was found to be 525 
3% and 33% larger than the removal observed in raw wastewater under corre-526 
sponding redox conditions.12 In contrast, Thai et al.13 found 25% and 40% en-527 
hancement of COC removal in gravity sewer (aerobic/anaerobic) and rising 528 
sewer (anaerobic) conditions, respectively compared to removal with 529 
wastewater only. In our study, CE biotransformation kinetics obtained under 530 
aerobic and anaerobic biofilms were comparable (kbiof,ae,CE=0.68 L gTSS-1 d-1, 531 
kbiof,an,CE=0.51 L gTSS-1 d-1). BE is formed from COC and CE transformations 532 
and also transformed to another unknown transformation product 533 
(kbiof,ae,BE=2.00 L gTSS-1 d-1, kbiof,an,BE=0.95 L gTSS-1 d-1). Values of k’biof  (m3 534 
m-2 d-1) estimated in this study (SI, Table S4) for overall COC, BE and CE for 535 
aerobic biofilms (k’biof,ae,COC=0.13 m3 m-2 d-1, k’biof,ae,BE=0.57 m3 m-2 d-1, 536 
k’biof,ae,CE=0.39 m3 m-2 d-1) are almost 4 times, 34 and 2 times higher than the 537 
values reported by McCall et al.14 (aerobic biofilms at 21°C). In contrary, for 538 
BE, no transformation by in-sewer suspended solids and sewer biofilms was 539 
reported.13 The differences are possibly due to different microbes residing in 540 
the biofilms in these studies.  541 
Heroin. Transformation of heroin biomarkers was assumed to follow the path-542 
ways previously described for human metabolism24,35,46, namely two-step de-543 
acetylation to 6MAM and to MOR. MORG was also considered to be trans-544 
formed to MOR via deconjugation.47 It was hypothesized that COE was not 545 
only transformed to NCOE by sewer biofilms but also to MOR as it was ob-546 
served in raw wastewater under anaerobic conditions.37 Nevertheless, biofilm-547 
mediated biotransformation processes could be described with transformation 548 
pathways similar to human metabolism. HER was rapidly removed in both 549 
sewer biofilms (similarly to raw wastewater (SI, Figure S9), with higher bio-550 
transformation kinetics in anaerobic biofilms (kbiof,ae,HER=4.43 L gTSS-1 d-1, 551 
kbiof,an,HER=22.14 L gTSS-1 d-1). Likewise, a five-fold increase of 6MAM bio-552 
transformation kinetics was observed in anaerobic biofilms (kbiof,ae,6MAM =1.11 553 
L gTSS-1 d-1, kbiof,an,6MAM=6.45 L gTSS-1 d-1). These differences cannot be ex-554 
plained only by considering differences in the removal of 6MAM in aerobic 555 
and anaerobic biofilms (i.e. 33% and 59% in aerobic and anaerobic biofilms in 556 
12 h experimental time (SI, Figure S9). Thus, additional processes are assumed 557 
to be involved, notably, the formation of 6MAM from HER. Given that the 558 
6MAM biotransformation by in-sewer suspended solids is significantly lower 559 
than in biofilms, the total % removal is not substantially different from those 560 
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reported by Thai et al.13 However, McCall et al.14 found 3 times higher bio-561 
transformation rate for 6MAM by aerobic biofilm compared to in-sewer sus-562 
pended solids. In this study, as to pathway identification, no additional trans-563 
formation product of HER was considered when assessing the conservation of 564 
HER mass. Moreover, MORG was found to be transformed only by anaerobic 565 
sewer biofilm (kbiof,an,MORG =2.03 L gTSS-1 d-1) – a rate approximately 6 times 566 
lower than that by in-sewer suspended biomass.12 Due to rapid aerobic trans-567 
formation of MORG in the bulk, no aerobic biofilm-induced removal was ob-568 
served for MORG. High transformation of MORG was also observed by Senta 569 
et al.8 in wastewater.  570 
Biotransformation rates obtained for COE and NOE in biofilms are at a mod-571 
erate level, with NCOE having higher transformation under anaerobic condi-572 
tions. The simulation model identified can effectively simulate the fate of HER 573 
and 6-MAM transformation in the BT-P2 independent datasets, thereby vali-574 
dating the modelling approach.  575 
THC. In untreated wastewater, THCOH was not found to be a transformation 576 
product of THC.12 Accordingly separate transformation pathways were as-577 
sumed for THC and THCOH in sewer biofilms. Based on pathways suggested 578 
in literature,35 THCCOOH was considered to be formed from THCOH.35 As a 579 
result of poor data quality, no clear conclusion could be drawn for THC bio-580 
transformation especially under anaerobic conditions. Moreover, the 581 
kbiof,ae,THC=0 as THC removal was completely attributed to partitioning to the 582 
external tank and abiotic hydrolysis. Hence, model calibration could not be 583 
performed using THC data set (SI, Figure S10). THCOH exhibited comparably 584 
high biotransformation rate constants (kbiof,ae,THCOH=21034 L gTSS-1 d-1, 585 
kbiof,an,THCOH=5066 L gTSS-1 d-1), which were also observed for THCCOOH bi-586 
otransformation in the anaerobic biofilm (kbiof,an,THCCOOH=3272 L gTSS-1 d-1).  587 
We note that the high kbiof values corresponded to high Kdf  values for these 588 
chemicals (SI Table S4), a factor that makes THCOH and THCCOOH less bi-589 
oavailable for biotransformation. Interestingly, aerobic THCCOOH biotrans-590 
formation obtained (kbiof,ae,THCCOOH=133 L gTSS-1 d-1) was lower than that un-591 
der anaerobic conditions.  592 
The impact of mass transfer limitation. Compared to common growth sub-593 
strates, illicit drug biomarkers are relatively large molecules. The average mo-594 
lar volume, V1 (cm-3 mol-1), of biomarkers in this study is 250 cm-3 mol-1, sig-595 
nificantly larger than the molar volume of readily biodegradable substrates 596 
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such as acetate (56.1 cm-3).48 Therefore, the comparably high molar volume is 597 
assumed to significantly impact diffusivity of drug biomarkers in biofilm.  598 
In general, the concentration in the boundary layer is proportional to the ratio 599 
of convective mass transfer (i.e. axial flow in biofilm reactor) to diffusive mass 600 
transport (Sh number). According to eq. 5, molecules with a higher molar vol-601 
ume and low diffusivity are expected to have lower boundary layers (SI Figure 602 
S1). In biofilm modeling studies, typically an average boundary layer is as-603 
sumed for all chemicals, under the condition that this approximation does not 604 
impact the accuracy of predictions; this, however, is generally done without 605 
proper error assessment. Figure 4 (Y-Z axis) illustrates the impact of the choice 606 
of boundary layer thickness on the accuracy of estimation of biotransformation 607 
rate, kf, for the example of MEPH and HER in aerobic biofilms. Estimated 608 
values for a range of boundary layer thicknesses (5 to 100 μm) together with 609 
discretization number (10 to 100) were compared with reference predictions 610 
for MEPH (30 μm) and HER (20 μm) with discretization number of 100. These 611 
results indicate that the impact of the boundary layer thickness on parameter 612 
estimates (i) is compound-specific; and (ii) varies by the discretization number 613 
employed (Figure 4 X-Z axis). A higher influence was observed for more re-614 
active compounds, i.e. HER, at lower discretization numbers. In Figure 4, red 615 
dots denote the values employed in this study (discretization number=80 lay-616 
ers; boundary layer thickness=23 μm). Furthermore, diffusion of HER and 617 
MEPH was compared in aerobic and anaerobic biofilms through simulation of 618 
diffusive transport, considering negligible partitioning to solids and transfor-619 
mation (SI Figure S12). Following the spiking of internal standards in BT-P1 620 
experiments, the concentrations in the bulk phase of the reactors were predicted 621 
to reach an equilibrium level after 2 h in aerobic biofilms and 4 h in anaerobic 622 
biofilms. These delays show the impact of mass transfer limitation across the 623 
boundaries of biofilm and liquid phase – a factor that necessitates an effective 624 
diffusion modelling for which we provided an example here. Moreover, the 625 
recirculation between external tank and reactor cause additional limiting step 626 
for reaching equilibrium. An example of concentration profile inside the bio-627 
film is also presented for MEPH (SI, Figure S13).  628 
Transformation in raw wastewater and sewer biofilms – A comparison. 629 
Biotransformation rate constants in sewer biofilms kbiof estimated in this study 630 
were compared rate constants in the presence of suspended solids, kbio (Figure 631 
5).12 Under aerobic conditions (reproducing a gravity sewer), most biomarkers 632 
exhibited similar kbiof and kbio values (see error bars in Figure 5). Biofilm-me-633 
diated transformations were found to be dominant for COE and NCOE, whilst 634 
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the majority of MORG and MOR transformation occurred in the bulk water by 635 
suspended biomass. Under anaerobic conditions, MEPH, METD, COC, EME, 636 
CE, THCOH, and THCCOOH were found to be biotransformed only in bio-637 
films. Moreover, no additional major transformation products for HER and 638 
MORG, other than 6MAM and MOR, respectively, were identified in the bio-639 
film reactors, as opposed to raw wastewater.  640 
Future perspectives. In this study, we assessed the transformation of 16 drug 641 
biomarkers in biofilm reactors under aerobic and anaerobic conditions, repre-642 
senting typical conditions in gravity and pressure sewers (respectively). This 643 
investigation complemented our previous study12 on the fate of drug bi-644 
omarkers in raw sewage, in the presence of suspended biomass only. A com-645 
parative assessment of the results indicates that sewer biofilms enhance the 646 
transformation kinetics of many of selected drug biomarkers, particularly un-647 
der anaerobic conditions (Figure 5), likely due to higher anaerobic activity in 648 
biofilms than in suspended biomass. Under aerobic conditions, transformation 649 
kinetics in biofilms was overall comparable to  that observed for untreated 650 
sewage, indicating again limited stability of selected biomarkers. This evi-651 
dence suggests the necessity of accounting for biofilm-mediated transfor-652 
mation when predicting in-sewer fate of drug biomarkers. Moreover, for the 653 
reliable prediction of trace organic chemical fate in biofilm, the mathematical 654 
consistency of simulation model structures should be assessed.  655 
More observations are needed to validate sorption and transformation of THC 656 
in sewer biofilms. In this study all drug biomarkers (parents and metabolites) 657 
were spiked simultaneously to simulate environmentally-relevant conditions, 658 
i.e. the occurrence of drug biomarkers in sewer as a mixture. The developed 659 
model however could describe the transformations among biomarkers. Never-660 
theless, future experimental designs used could benefit from spiking unrelated 661 
biomarkers (e.g., in separate batch experiments) or using biomarkers with sev-662 
eral different labels, although resulting in a drastic increase of the cost of chem-663 
ical analysis. 664 
The microbial activity of the two biofilms in this study was characterized by 665 
monitoring utilization of primary substrates (e.g., organic carbon, sulfate) dur-666 
ing batch experiments. Our results showed substantial differences in microbial 667 
activity between the two biofilms assessed in this study, e.g., significantly 668 
higher sulfate-reducing activity in the anaerobic biofilm. In sewer systems, mi-669 
crobial functions and community of sewer biofilms vary over a sewer length 670 
likely as a result of changes in boundary conditions and gradients in substrate 671 
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concentrations and wastewater composition. To date, this has been demon-672 
strated for gravity sewers14. Hence, further research is required to characterize 673 
microbial activity of the sewer biofilms at different sewer locations and corre-674 
late the microbial community and activity with biotransformation rates. 675 
In this study, the aeration was performed in a separate tank and not directly in 676 
the biofilm reactor. The objective was to provide sufficient oxygen supply to 677 
ensure that most microorganisms would be exposed to aerobic conditions. It 678 
should be noted that (re)aeration may be different in full-scale sewer systems, 679 
being caused by flow fluctuations and mixing. The current study potentially 680 
offers the background for a combined modelling framework for real sewers, 681 
where switching functions based on dissolved oxygen concentration would al-682 
low differentiating between aerobic and anaerobic conditions. 683 
Although this study compared the biotransformation rate in raw wastewater 684 
and in biofilms, the contribution of each of these biotransformation processes 685 
to the overall drug biomarkers removal should be assessed. Moreover, the as-686 
sessment of drug abuse rates at catchment level should account for, im-687 
portantly, the layout of the sewer system, hydraulic conditions49 and the possi-688 
ble drug release patterns. Additionally, model-based back-calculation tools 689 
should account for abiotic processes and biotransformation induced by sus-690 
pended biomass and sewer biofilms.50 Hence, a reactive-transport model needs 691 
to be developed,  describing drug biomarkers transformation under steady-state 692 
and dynamic conditions. Transformation rates estimated in this study can be 693 
used to calibrate such simulation models. Our ongoing research50 is addressing 694 
the impact of neglecting in-sewer biotransformation on estimation of daily 695 
drug consumption in catchments using uncertainty analysis and measurements 696 
from sampling campaigns. Results presented in this study underscore the high 697 
level of complexity of in-sewer biomarker fate, of which the implications to 698 
wastewater-based epidemiological engineering are numerous.   699 
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Table 1.  Model state variables and parameters   850 
 851 
  852 
Symbol Definition Units Values 
Ab Biofilm area m2 4.10-3 
CR Concentration of drug biomarkers in reactor g L-1  
Cb Concentration of drug biomarkers inside biofilm g L-1  
CT Concentration of drug biomarkers in external tank bulk phase g L-1  
CTw 
Concentration of drug biomarkers sorbed onto external tank 
wall g L
-1  
d Gap between rotating drum and stationary cylinder (R2-R1) m 0.012 
dR Reactor Characteristic length (2d)  0.024 
D Diffusion coefficient of the soluble compounds into the biofilm m2 d-1 Table S2 
Dw Diffusion coefficient of the soluble compounds in water m2 d-1 Table S2 
f Dimensionless effective diffusivity - ae:0.68 an:0.38 
jb Flux of compounds between bulk phase and the biofilm g m-2 d-1  
kb Mass transfer coefficient between bulk phase and the biofilm m d-1  
kdes,w Desorption from reactor wall d-1 100 
Kdw Reactor wall–liquid partition coefficient  m3 m-2 Ramin et al.12 
Kd Suspended Solid–liquid partition coefficient  L gTSS-1 Ramin et al.12 
Kdf Suspended biofilm–liquid partition coefficient  L gTSS-1 Table S4 
kabio Abiotic transformation rate constant d-1 Ramin et al.12 
kbio TSS-normalized biotransformation rate constant L gTSS-1 d-1 Ramin et al.12 
kf Sewer biofilm biotransformation rate (eq. 9) d-1 Figure S11 
kbiof TSS-normalized Sewer biofilm biotransformation rate L gTSS-1 d-1 Table S4 
k'biof 
Area-to-volume-normalized Sewer biofilm biotransformation 
rate 
m3 m-2 d-1 Table S4 
Lb Concentration boundary layer  m 23.10-6 
M Biomarker molecular weight g mol-1 Table S2 
O Observed (measured) values   
P Predicted (simulated) values    
Qin,R Reactor inflow m3 d-1 4.10-3  
Qout,R Reactor outflow m3 d-1 4.10-3 
Qin,T External tank inflow m3 d-1 4.10-3 
Qout,T External tank outflow m3 d-1 4.10-3 
rR Reaction rate in reactor g L d-1  
rb Reaction rate in side biofilm g L d-1  
rT Reaction rate in external tank g L d-1  
R1 Reactor inner radios (outer radios of rotating drum) m 0.045 
R2 Reactor outer radios (inner radios of stationary cylinder) m 0.057 
VR Total reactor volume m3 9.61.10-4 
ū Average axial velocity inside reactor (a continuous operation; b: batch experiment) m s
-1 
a: 0.12.10-4 
a: 2.89.10-4 
Vb Biofilm volume m3 
ae: 1. 25.10-4 
an: 1.71.10-4 
VT Bulk volume in external volume m3 Figure S2 
V1 Molar volume cm3 g mole-1 Table S2 
XSS  Concentration of suspended solids gTSS L Table S3 
𝛥Z Discretization distance inside biofilm for spatial discretization 
of partial differential equations 
m ae:9.3 10
-6 
an: 12.8 10-6 
μw Dynamic viscosity of water (at ∼17°C)  kg m-1 s-1 1.07 10-3 
ν Kinematic viscosity of water (at ∼17°C) m-2 s-1 1.07 10-6 
σw Wet-surface-to-volume ratio m2 m-3   Figure S2 
Ω Angular velocity of rotating drum  rad d-1 2.09 
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 853 
Figure 1. Configuration of rotating biofilm reactor (on the left) connected to an external tank (on 854 
the right) during batch experiments.  The samples were taken from the outlet of the biofilm reac-855 
tor, on the top valve. Anaerobic or aerobic conditions were maintained in the external tank by 856 
sparging air or nitrogen, respectively, from a diffuser placed at the bottom of the tank.  A typical 857 
drug concentration profile inside the biofilm is also presented.  858 
 859 
 860 
Figure 2. Soluble COD, sulfate and ammonium concentrations measured during BT-P1 ex-861 
periments under aerobic and anaerobic conditions. Measurements before t=0 refer to samples 862 
taken prior to the spiking of standards, and the subsequent increase of soluble COD concen-863 
tration at t=0 should be associated with the addition of MeOH resulting from spiking of 864 
biomarkers mixture. Lines connecting data points are based on simple linear interpolation to 865 
show the trends. 866 
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 868 
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Figure 3. Experimental data and simulation results for biomarker transformations in sewer 869 
biofilm under aerobic and anaerobic conditions. Results are related to model calibration us-870 
ing BT-P1 experimental data and model validation using BT-P2 experimental data. THC 871 
data is presented in (SI, Figure S10). Markers are measured data and lines are simulation 872 
results. The shaded areas reflect 95% credibility interval of model prediction. 873 
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 874 
Figure 4. The impact of discretization number (number of discretization layers considered 875 
for numerical integration in biofilm) and boundary layer thickness on estimation of aerobic 876 
transformation rate, kf (d-1), for MEPH and HER. 190 scenarios were considered for each 877 
chemical. The parameter estimate at each scenario was compared with the reference scenario 878 
for each chemical. The reference scenario contained 100 layers using the accurate estimation 879 
of boundary layer thickness, i.e. 30 μm for MEPH and 20 μm for HER. Blue dots are the 880 
data resulted from scenarios and red dots correspond to the values chosen in this study (i.e. 881 
80 discretization number and 23 μm boundary layer thickness). Considering this choice re-882 
sulted in an acceptable error i.e. 0.4% for MEPH and 2% for HER. 883 
 884 
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 885 
Figure 5. Comparing the biotransformation of drug biomarkers in raw wastewater and bio-886 
transformation in sewer biofilms under aerobic (a), and anaerobic (b) conditions. For this 887 
comparison, TSS-normalized transformation rate constants in raw wastewater kbio (L gTSS-888 
1 d-1) reported in Ramin et al.12 are compared with sewer biofilm-mediated transformation 889 
rate constants, kbiof (L gTSS-1 d-1), from this study. Error bars identify the upper bound of the 890 
95% credibility interval of estimated parameters. 891 
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